Philips Begins Clinical Trial Enrolment for CHILL-MI Study
Royal Philips Electronics (NYSE: PHG, AEX: PHI) announced enrolment of the first patients in its CHILL-MI clinical study. CHILL-MI is a prospective, randomized, multi-center study designed to further evaluate the safety and effectiveness of the company's InnerCool RTx endovascular cooling system in patients suffering from ST-elevation myocardial infarction (STEMI).
Read more ...
New Silicon Probe Aids in Drug Discovery and Disease Diagnostics
IBM scientists have developed a flexible, non-contact microfluidic probe made from silicon that can aid researchers and pathologists to investigate critical tissue samples accurately for drug discovery and disease diagnostics.
Read more ...
More Investment Needed in Health ICTs to Improve Healthcare Delivery
COCIR published the results of a survey conducted among European acute care hospitals on the availability, use and investment plans for health information and communication technologies (health
ICTs). This market, worth €2.5 billion in 2010, is estimated to grow moderately to €2.8 billion by 2015.
Read more ...
Saturn Deploys NHS Digital Signage Network for North West Trust
Wrightington, Wigan & Leigh (WWL) NHS Foundation Trust turned to healthcare digital signage specialist Saturn to design and deploy a screen network across three sites within an ambitious two week window.
Read more ...
Mid Staffordshire NHS Foundation Trust Selects System C for EPR Project
Mid Staffordshire NHS Foundation Trust has selected System C to supply and implement its Medway patient administration and electronic patient record (PAS/EPR) system across the Trust.
Read more ...
Catharina Hospital and Philips Launch Unique Dutch Social Media Initiative
For the first time in the Netherlands, the treatment of a patient with a heart rhythm disorder can be followed via social media. Sharing the experience of a real patient is part of a unique initiative organized by the Catharina Hospital (Eindhoven, The Netherlands) and Philips.
Read more ...
MyAsthma App - a New Dimension in Asthma Control
GlaxoSmithKline (GSK) has announced the launch of MyAsthma, the UK's first, free personalised health application (app) designed to help people over the age of 12 take greater control of their asthma.
Read more ...